基本信息
浏览量:1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
As a research scientist with a Master's Degree and PhD in molecular and cellular biology, I have over 20 years of experience in the pharmaceutical industry focused on drug discovery R&D, primarily in Oncology, as well as in additional therapeutic areas such as hematology, CNS, Rheumatoid arthritis, and sepsis.
Throughout my career, I have been involved in several internal and external projects in preclinical stages, from target validation and lead identification up to phase I/II clinical trials. I have worked across biology, chemistry, and pharmacology departments to define assays in drug screening for selecting new chemical entities for selectivity, specificity, and efficacy to apply to Structure Activity Relationship (SAR) from Hit ID, H2L and LO to PC.
I am a subject matter expert in flow cytometry and phenotypic screening applied to drug discovery using polychromatic and spectral flow cytometry, high content analysis, and mass cytometry. I have also been a member of the targets identification team and cellular large-scale screenings for future project development and a member of the immuno-oncology team.
In addition, I have 10 years of experience in collaboration, out-licensing, partnership, and projects co-development with startup, CRO, and middle cap pharmaceutical companies. As a project manager, I have managed budget allocation/planning and have been involved in laboratory facility and equipment innovation/reorganization, and have been responsible for workers' health and safety.
I have assisted and collaborated with the business development team, making presentations to internal/external stakeholders, CROs, and partners, as well as at conferences. I am interested in regulatory aspects such as GLP and GCP for laboratory clinical trials.
I am the author of several book chapters on the use of flow cytometry in drug development, 40 peer-reviewed manuscripts, and one patent. My main interests include DNA damage response, immuno-oncology, cell cycle inhibitors, phenotypic screening, flow cytometry, and innovation.
I am excited to bring my extensive skills and expertise to new challenges and opportunities in the pharmaceutical industry.
研究兴趣
论文共 54 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Riccardo Colombo,Marina Caldarelli, Milena Mennecozzi,Maria Laura Giorgini,Francesco Sola,Paolo Cappella,Claudia Perrera,Stefania Re Depaolini, Luisa Rusconi,Ulisse Cucchi,Nilla Avanzi,Jay Aaron Bertrand,
crossref(2023)
crossref(2023)
Riccardo Colombo,Marina Caldarelli, Milena Mennecozzi,Maria Laura Giorgini,Francesco Sola,Paolo Cappella,Claudia Perrera,Stefania Re Depaolini, Luisa Rusconi,Ulisse Cucchi,Nilla Avanzi, Jay Aaron Bertrand,
crossref(2023)
Paolo Ubezio,Monica Lupi, Davide Branduardi,Paolo Cappella, Edoardo Cavallini,Valentina Colombo,Giada Matera, Claudia Natoli, Daniela Tomasoni, Maurizio D'Incalci
crossref(2023)
Paolo Ubezio,Monica Lupi, Davide Branduardi,Paolo Cappella, Edoardo Cavallini,Valentina Colombo,Giada Matera, Claudia Natoli, Daniela Tomasoni, Maurizio D'Incalci
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn